PharmaSights
PharmaSights is a Toronto-based SaaS company, founded in 2023, that provides biopharma commercial teams with pre-prepared market intelligence across therapeutic areas, drug modalities, and 2024-2028 forecasts, sold via annual enterprise subscriptions.
- Company typePrivate
- Founded2023
- HeadquartersToronto, Canada
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What PharmaSights does
PharmaSights is a Toronto, Canada-based software company founded in 2023 by Alex Bonebakker that sells a biopharma commercial intelligence SaaS platform to pharmaceutical and biotechnology commercial organizations. It targets the pain points of fragmented data sources, slow procurement, weeks of data cleaning, and stagnant PowerPoint-based insights by offering always-available, pre-prepared market landscapes rather than custom-built analyses.
The platform consists of four interconnected products: Market Scanner (market mapping across 13 therapeutic areas), Modality Scanner (market mapping across 9 drug modality categories including small molecules, monoclonal antibodies, bispecific antibodies, ADCs, cell therapies, and gene therapies), Market Forecaster (2024-2028 market forecasts with an NLP-driven chatbot for natural-language querying), and Biopharma Book (interactive revenue and portfolio visualization for leading biopharma companies). Together these tools claim coverage of 95%+ global biopharma sales across more than 40 diseases. The underlying architecture integrates a data warehouse, analytics layer, and visualization layer into a single stack.
PharmaSights operates a direct enterprise sales motion with demos and free trials as the primary acquisition pathway, priced via annual subscriptions negotiated by the sales team. The company is founder-led, privately held, and bootstrapped with 1-10 employees as of the latest available data. Marketing is driven by a blog, email newsletter, LinkedIn presence, and earned media features in AlphaSense and BioKnow. The company participated in BIO International 2024 in San Diego as its primary in-person industry event to date.
PharmaSights firmographics
Firmographics- Name
- PharmaSights
- Legal name
- PharmaSights
- Website
- https://pharmasights.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- PharmaSights is a Toronto-based SaaS company, founded in 2023, that provides biopharma commercial teams with pre-prepared market intelligence across therapeutic areas, drug modalities, and 2024-2028 forecasts, sold via annual enterprise subscriptions.
- Ownership category
- akta.pro rank
Where PharmaSights is headquartered
LocationHeadquarters
- HQ city
- Toronto
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
PharmaSights business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- Subscription Platform Access: The platform operates on a subscription model providing access to pre-prepared market landscapes, forecasting tools, and commercial intelligence dashboards. Customers can request demos and free trials before purchasing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise subscription with demo/free trial available |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
PharmaSights product offering
Product offeringCore offering
PharmaSights provides a SaaS biopharma commercial intelligence platform that delivers pre-prepared, always-available market landscapes covering 95%+ of global biopharma sales across 40+ diseases. The platform integrates a data warehouse, analytics, and visualization tooling into a unified offering, enabling biopharma commercial teams to drill from market-level to company-level to drug-level views of the branded Rx landscape.
Product overview
PharmaSights is a next-generation biopharma commercial intelligence platform that delivers pre-prepared, always-available market landscapes for biopharma commercial teams. The platform combines data integration, strategic analytics, and visualization technology into a unified SaaS solution. The core portfolio consists of four interconnected tools: Market Scanner (covering 13 therapeutic areas for branded Rx landscape analysis), Market Forecaster (with built-in NLP chatbot for market forecasting 2024-2028), Modality Scanner (covering 9 drug modality market maps), and Biopharma Book (providing revenue analysis and portfolio visualization for leading biopharma companies). Together these products provide 95%+ global biopharma sales coverage across 40+ diseases with extensive datapoints.
Differentiator
Problem solved
Functional benefit
Products and services
- Market Scanner Dynamic, drillable and filterable market mapping tool that helps biopharma commercial teams quickly understand the 360-degree branded Rx landscape across 13 therapeutic areas.
- Modality Scanner
- Market Forecaster
- Biopharma Book
Quantifiable outcome
- Saves hours of time finding biopharma commercial intelligence
Companies that use PharmaSights
Customer profileSegments1 record
Ideal customer profiles1 record
PharmaSights technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature4 records
PharmaSights partnerships and signals
Strategic signalScale indicators3 records
Recent moves5 records
Expansion highlights5 records
PharmaSights competitors and assessment
Company assessmentDirect peers
- GlobalData Healthcare: GlobalData provides market intelligence, forecasts, and company/therapeutic-area analytics for the pharmaceutical industry. It offers biopharma commercial intelligence products overlapping directly with PharmaSights' market-scanner and forecasting use cases.
- Evaluate Pharma (Evaluate Ltd): Evaluate Pharma provides biopharma sales forecasts, consensus models, and commercial intelligence covering the global pharmaceutical market. It is the closest direct competitor to PharmaSights' Market Forecaster and Market Scanner products in therapeutic-area forecasting and branded-Rx landscape analysis.
- Komodo Health: Komodo Health offers healthcare and life-sciences commercial intelligence using patient-level data and analytics for biopharma commercial teams. It competes in the broader biopharma commercial intelligence category where PharmaSights operates.
- Citeline (Informa Pharma Intelligence): Citeline delivers pharma commercial intelligence, pipeline tracking, trial data, and forecast analytics across the biopharma value chain. It competes directly with PharmaSights in providing therapeutic-area and modality-level commercial intelligence to biopharma commercial teams.
- AlphaSense: AlphaSense is an enterprise market intelligence and search platform that has featured PharmaSights among its biopharma commercial intelligence solutions. It competes in the broader market intelligence space with AI-powered search across earnings, broker research, and proprietary datasets.
- Definitive Healthcare: Definitive Healthcare provides healthcare commercial intelligence on providers, physicians, and biopharma products, including market analytics for life-sciences commercial teams. Its biopharma commercial analytics overlap with PharmaSights' market-mapping use cases.
Emerging players
- EVERSANA: EVERSANA provides life-sciences commercial services and data/analytics tools for biopharma brand strategy and market access. It overlaps with PharmaSights in serving commercial teams at biopharma companies on market intelligence and strategic insights.
Broad incumbents
- IQVIA: IQVIA is the largest life-sciences commercial intelligence and data provider, offering deep sales, prescription, and forecasting datasets across all biopharma segments. It is the broad incumbent against which PharmaSights positions its integrated smaller-footprint platform.
Others
- Clarivate (Cortellis / DRG): Clarivate operates Cortellis and former DRG Decision Resources Group biopharma intelligence assets spanning pipeline, clinical, and commercial analytics. It is a broad incumbent covering biopharma commercial intelligence as part of a much wider IP and life-sciences portfolio.
- Tracelink: Tracelink provides biopharma commercial analytics focused on patient journeys, adherence, and brand performance. While more focused on patient/prescriber analytics than market forecasting, it serves an overlapping customer base of biopharma commercial teams.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
PharmaSights social profiles
Digital presencePharmaSights financial estimates
Financial estimateRevenue estimate
Valuation estimate
PharmaSights leadership team
Management profileNumber of profiles
Profiles1 record
PharmaSights funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PharmaSights M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PharmaSights
What does PharmaSights do?
PharmaSights provides a SaaS biopharma commercial intelligence platform that delivers pre-prepared, always-available market landscapes covering 95%+ of global biopharma sales across 40+ diseases. The platform integrates a data warehouse, analytics, and visualization tooling into a unified offering, enabling biopharma commercial teams to drill from market-level to company-level to drug-level views of the branded Rx landscape.
Is PharmaSights a public or private company?
PharmaSights is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was PharmaSights founded?
PharmaSights was founded in 2023. It employs 1 to 10 people.
Where is PharmaSights based?
PharmaSights is headquartered in Toronto, Canada, in the North America region.
How does PharmaSights make money?
One revenue line is on record: subscription Platform Access.
Who are PharmaSights's main competitors?
Direct peers on record are GlobalData Healthcare, Evaluate Pharma (Evaluate Ltd), Komodo Health, Citeline (Informa Pharma Intelligence), AlphaSense and Definitive Healthcare. EVERSANA is listed as an emerging player. IQVIA is listed as a broad incumbent. Others are Clarivate (Cortellis / DRG) and Tracelink.
Does PharmaSights have an API?
No public API is recorded for PharmaSights.